WuXi Biologics Reports Solid 2024 Interim Results
Revenue increased by 1.0%YoY to RMB 8,574.2 million Non-COVID revenue grew by 7.7% YoY,with non-COVID late-phase & commercialmanufacturing YoY growth of 11.7%
WuXi Biologics Reports Solid 2024 Interim Results
Revenue increased by 1.0%YoY to RMB 8,574.2 million Non-COVID revenue grew by 7.7% YoY,with non-COVID late-phase & commercialmanufacturing YoY growth of 11.7%
Persistent Donations Transform Children's Lives
Sustained contributions lead to lasting and impactful transformations. #SavetheChildrenHK #ChildGuardian #MonthlyDonation
HONG KONG,Aug. 22,2024-- Kirloskar,a leading multi-engineering conglomerate in India celebrates its 16th consecutive year of partnership with CNN International Commercial (CNNIC) to promote sustainab
Pan Pacific Hotels Group to Operate 7th Property in Malaysia, Second in Penang
Gurney Bay Hotel,A PARKROYAL Hotel marks fourth opening for Pan Pacific Hotels Group in Southeast Asia this year
SINGAPORE,Aug. 22,2024-- Organised by Constellar,in partnership with DECHEMA Ausstellungs-GmbH (DECHEMA Exhibitions)[1],the inaugural Process Innovation Asia Pacific - Powered by ACHEMA (PIA) will be
GarudaMiles enhances reward utility and flexibility by leveraging Plusgrade\'s decades of loyalty expertise and strategic data insights through their loyalty business unit,Points.
AWC Ignites the Future of Mobility and Reshapes the Global Automotive Industry
SHENZHEN,China,Aug. 23,2024-- The transformation of the automotive industry accelerated in the first half of 2024 with the steady rise in production and sales of new energy vehicles. By the end of Jun
Multiplier\'s White Paper Reveals Strategies for Overcoming the Accountant Shortage NEW YORK,Aug. 22,2024--As over 75% of Certified Public Accountants (CPAs) reached retirement age in 2019 and fewer
SINGAPORE,Aug. 23,2024--Muster Marine Pte Ltd,a premier provider of marine insulation and engineering solutions,is pleased to announce a significant expansion of its services and product offerings to
SHANGHAI,Aug. 23,2024-- GenFleet Therapeutics,a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology,announced China\'s National Medical Products Administ